Literature DB >> 11414758

Electroconvulsive thresholds of inbred mouse strains.

W N Frankel1, L Taylor, B Beyer, B L Tempel, H S White.   

Abstract

The electroconvulsive threshold (ECT) test is used commonly in the screening of anti-epileptic drugs in rodent models, but little is known about its genetic or mechanistic basis. Thresholds for minimal clonic, maximal tonic, or psychomotor (partial) seizures were determined in 16 different inbred mouse strains in two different laboratories. A wide range of thresholds was observed, suggesting that a variety of neuroexcitability alleles exist in inbred strains. Although there was generally good cross-strain correlation between the three seizure types, several outlier strains were detected, showing that genetically encoded differences can affect the ability of a particular seizure type to spread through the brain. Furthermore, the relative seizure susceptibility of a strain was comparable between the two laboratories, suggesting that despite different test sites, instrumentation, and personnel, the ECT assay is portable and that common inbred strains can often be relied upon as calibration standards. Last, the ECT paradigm was also sensitive enough to detect single locus differences, laying the groundwork for mutation screens for new neuroexcitability models. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11414758     DOI: 10.1006/geno.2001.6564

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  58 in total

1.  Factors affecting outcomes of pilocarpine treatment in a mouse model of temporal lobe epilepsy.

Authors:  Paul S Buckmaster; Megan M Haney
Journal:  Epilepsy Res       Date:  2012-06-19       Impact factor: 3.045

Review 2.  The relevance of individual genetic background and its role in animal models of epilepsy.

Authors:  P Elyse Schauwecker
Journal:  Epilepsy Res       Date:  2011-10-15       Impact factor: 3.045

Review 3.  Genetic influences on ketogenic diet efficacy.

Authors:  Stacey B B Dutton; Andrew Escayg
Journal:  Epilepsia       Date:  2008-11       Impact factor: 5.864

4.  Lack of Chronic Histologic Lesions Supportive of Sublethal Spontaneous Seizures in FVB/N Mice.

Authors:  Rebecca A Kohnken; Denise J Schwahn
Journal:  Comp Med       Date:  2016-04       Impact factor: 0.982

Review 5.  Ion channels in genetic and acquired forms of epilepsy.

Authors:  Holger Lerche; Mala Shah; Heinz Beck; Jeff Noebels; Dan Johnston; Angela Vincent
Journal:  J Physiol       Date:  2012-10-22       Impact factor: 5.182

6.  Dissociation of seizure traits in inbred strains of mice using the flurothyl kindling model of epileptogenesis.

Authors:  Dominick Papandrea; Tara M Anderson; Bruce J Herron; Russell J Ferland
Journal:  Exp Neurol       Date:  2008-10-07       Impact factor: 5.330

7.  Genetic and phenotypic analysis of seizure susceptibility in PL/J mice.

Authors:  Toshimori Kitami; Sheila Ernest; Laura Gallaugher; Lee Friedman; Wayne N Frankel; Joseph H Nadeau
Journal:  Mamm Genome       Date:  2004-09       Impact factor: 2.957

8.  Fine mapping of an epilepsy modifier gene on mouse Chromosome 19.

Authors:  Sarah K Bergren; Elizabeth D Rutter; Jennifer A Kearney
Journal:  Mamm Genome       Date:  2009-06-10       Impact factor: 2.957

9.  Mice with deficiency of G protein gamma3 are lean and have seizures.

Authors:  William F Schwindinger; Kathryn E Giger; Kelly S Betz; Anna M Stauffer; Elaine M Sunderlin; Laura J Sim-Selley; Dana E Selley; Sarah K Bronson; Janet D Robishaw
Journal:  Mol Cell Biol       Date:  2004-09       Impact factor: 4.272

10.  Fine mapping of a seizure susceptibility locus on mouse Chromosome 1: nomination of Kcnj10 as a causative gene.

Authors:  Thomas N Ferraro; Gregory T Golden; George G Smith; James F Martin; Falk W Lohoff; Tracy A Gieringer; Deborah Zamboni; Candice L Schwebel; Danielle M Press; Stephanie O Kratzer; Hongyu Zhao; Wade H Berrettini; Russell J Buono
Journal:  Mamm Genome       Date:  2004-04       Impact factor: 2.957

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.